Results 111 to 120 of about 1,213 (150)

Use of SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors in Pulmonary Hypertension. [PDF]

Circ Heart Fail
Aguado B, Ruffenach G, Lacoste-Palasset T, Görlach A, Riou M, Gourmelon M, Bauer F, Humbert M, Schini-Kerth V, Vachiéry JL, Montani D, Antigny F.   +11 more
europepmc   +1 more source

Pharmacological research of a novel selective SGLT2 inhibitor, tofogliflozin

, 2014
openaire   +1 more source

Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular Carcinoma. [PDF]

Life (Basel)
Chung HH.
europepmc   +1 more source

The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence. [PDF]

Life (Basel)
Gurgoglione FL, Covani M, Torlai Triglia L, Benatti G, Donelli D, Bianconcini M, Solinas E, Tadonio I, Denegri A, De Gregorio M, Dallaglio G, Dei Cas A, Bonadonna RC, Vignali L, Niccoli G.   +14 more
europepmc   +1 more source

The comparative efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists on metabolic benefits in T2DM patients: a systematic review and network meta-analysis. [PDF]

Eur J Med Res
Tong J, Li N, Hu F, Yue Y.
europepmc   +1 more source

Pharmacological profile of tofogliflozin, a novel SGLT2 inhibitor, in preclinical studies

, 2014
openaire   +1 more source

Pharmacological profile of tofogliflozin, a novel SGLT2 inhibitor, in preclinical studies

Pharmacological profile of tofogliflozin, a novel SGLT2 inhibitor, in preclinical studies
openaire  

Some of the next articles are maybe not open access.

Related searches:

Impact of tofogliflozin on hepatic outcomes: a systematic review

European Journal of Clinical Pharmacology, 2023
Studies have demonstrated a high prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients. The aim was to review the effect of tofogliflozin on hepatic outcomes in T2DM patients.A literature search in PubMed, Science Direct and Cochrane Central Register of Controlled Trials was conducted for randomised ...
Rizwana Parveen, Nidhi Bharal Agarwal
exaly   +3 more sources

Tofogliflozin Salt Cocrystals with Sodium Acetate and Potassium Acetate

Chemical and Pharmaceutical Bulletin, 2018
We investigated the salt cocrystals formed by tofogliflozin with sodium acetate and potassium acetate by determining the crystal structures of the salt cocrystals and characterizing the solid states. The salt cocrystal screening using the slurry method and the liquid-assisted grinding method resulted in the formation of tofogliflozin-sodium acetate 1 : 
Noriyuki Takata, Satoshi Tanida, Koji Shiraki   +2 more
exaly   +4 more sources